DarioHealth Corp rises as Q1 loss narrows
** Shares of digital therapeutics co DarioHealth Corp
DRIO.O up 8.38% at $4.01
** Co reports Q1 net loss of $12.8 mln, compared to a net
loss of $15.9 mln a year earlier
** Business-to-Business (B2B) revenue continued to increase,
representing about 70% of total revenue during Q1, up from 56% a
year earlier- co
** DRIO stock down 6.78% YTD
(Reporting by Rupali Chaudhary in Bengaluru)
((Rupali.chaudhary@thomsonreuters.com))
Recent news on DarioHealth
See all newsNASDAQ RESUMED AT 10:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
DarioHealth Corp reports results for the quarter ended June 30 - Earnings Summary
DarioHealth Q2 revenue falls on pharma exit; gross margin improves
DarioHealth Corp expected to post a loss of $1.21 a share - Earnings Preview